Literature DB >> 11547899

Integrin laminin receptors and breast carcinoma progression.

A M Mercurio1, R E Bachelder, J Chung, K L O'Connor, I Rabinovitz, L M Shaw, T Tani.   

Abstract

This review explores the mechanistic basis of breast carcinoma progression by focusing on the contribution of integrins. Integrins are essential for progression not only for their ability to mediate physical interactions with extracellular matrices but also for their ability to regulate signaling pathways that control actin dynamics and cell movement, as well as for growth and survival. Our comments center on the alpha6 integrins (alpha6beta1 and alpha6beta4), which are receptors for the laminin family of basement membrane components. Numerous studies have implicated these integrins in breast cancer progression and have provided a rationale for studying the mechanistic basis of their contribution to aggressive disease. Recent work by our group and others on mechanisms of breast carcinoma invasion and survival that are influenced by the alpha6 integrins are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11547899     DOI: 10.1023/a:1011323608064

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  73 in total

1.  Migration of breast epithelial cells on Laminin-5: differential role of integrins in normal and transformed cell types.

Authors:  G E Plopper; S Z Domanico; V Cirulli; W B Kiosses; V Quaranta
Journal:  Breast Cancer Res Treat       Date:  1998-09       Impact factor: 4.872

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 3.  An overview of epithelio-mesenchymal transformation.

Authors:  E D Hay
Journal:  Acta Anat (Basel)       Date:  1995

4.  Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors.

Authors:  H Mizushima; Y Miyagi; Y Kikkawa; N Yamanaka; H Yasumitsu; K Misugi; K Miyazaki
Journal:  J Biochem       Date:  1996-12       Impact factor: 3.387

5.  Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells.

Authors:  R Mukhopadhyay; R L Theriault; J E Price
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

6.  The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice.

Authors:  U M Wewer; L M Shaw; R Albrechtsen; A M Mercurio
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

7.  Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.

Authors:  K Nakatani; D A Thompson; A Barthel; H Sakaue; W Liu; R J Weigel; R A Roth
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 8.  Epithelial-mesenchymal transitions in cancer progression.

Authors:  C Birchmeier; W Birchmeier; B Brand-Saberi
Journal:  Acta Anat (Basel)       Date:  1996

Review 9.  E-cadherin as an invasion suppressor.

Authors:  W Birchmeier; J Hülsken; J Behrens
Journal:  Ciba Found Symp       Date:  1995

10.  The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures.

Authors:  I Rabinovitz; A M Mercurio
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  29 in total

Review 1.  Integrins in mammary gland development and differentiation of mammary epithelium.

Authors:  Ilaria Taddei; Marisa M Faraldo; Jérôme Teulière; Marie-Ange Deugnier; Jean Paul Thiery; Marina A Glukhova
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

Review 2.  Microenvironmental control of the breast cancer cell cycle.

Authors:  Xun Guo; Yuehan Wu; Helen J Hathaway; Rebecca S Hartley
Journal:  Anat Rec (Hoboken)       Date:  2012-01-24       Impact factor: 2.064

Review 3.  Cell-matrix interactions in mammary gland development and breast cancer.

Authors:  John Muschler; Charles H Streuli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

4.  Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma.

Authors:  Wu Yang; Maolin He; Jinmin Zhao; Zhe Wang
Journal:  Med Oncol       Date:  2014-01-01       Impact factor: 3.064

5.  Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1.

Authors:  Edward Htun van der Horst; Yan Y Degenhardt; Astrid Strelow; Anthony Slavin; Lawrence Chinn; Jessica Orf; Minqing Rong; Shyun Li; Lei-Hoon See; Ken Q C Nguyen; Timothy Hoey; Holger Wesche; Scott Powers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

6.  Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro.

Authors:  Yaongamphi Vashum; Riya Premsingh; Amuthavalli Kottaiswamy; Mathangi Soma; Abirami Padmanaban; Parkavi Kalaiselvan; Shila Samuel
Journal:  Mol Biol Rep       Date:  2020-12-08       Impact factor: 2.316

7.  Mouse fibroblasts null for the long isoform of β1,4-galactosyltransferase-I show defective cell-matrix interactions.

Authors:  Brooke H Elder; Barry D Shur
Journal:  Biochem Biophys Res Commun       Date:  2016-08-20       Impact factor: 3.575

8.  Expression of laminin isoforms, receptors, and binding proteins unique to nucleus pulposus cells of immature intervertebral disc.

Authors:  Jun Chen; Liufang Jing; Christopher L Gilchrist; William J Richardson; Robert D Fitch; Lori A Setton
Journal:  Connect Tissue Res       Date:  2009       Impact factor: 3.417

9.  Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.

Authors:  Brendan C Luey; Felicity E B May
Journal:  Mol Cancer       Date:  2016-01-22       Impact factor: 27.401

10.  BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells.

Authors:  Beate C Litzenburger; Hyun-Jung Kim; Isere Kuiatse; Joan M Carboni; Ricardo M Attar; Marco M Gottardis; Craig R Fairchild; Adrian V Lee
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.